J. Lade-Keller

发表

TGF‐β1 and TNF‐α differentially regulate Twist1 mediated resistance towards BRAF/MEK inhibition in melanoma

J. Brandner, H. Schaider, S. Joshi, 2013, Pigment cell & melanoma research.

BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions

P. Guldberg, P. Toft, S. Heegaard, 2016, Acta ophthalmologica.

Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy

M. Stougaard, P. Meldgaard, J. Lade-Keller, 2022, Journal of Clinical Pathology.

KIT is a frequent target for epigenetic silencing in cutaneous melanoma.

P. Guldberg, R. Riber‐Hansen, T. Steiniche, 2015, The Journal of investigative dermatology.

Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker

S. Hamilton-Dutoit, H. Schmidt, P. Guldberg, 2014, Journal of Clinical Pathology.

Telomerase reverse transcriptase promoter mutations and solar elastosis in cutaneous melanoma

R. Riber‐Hansen, T. Steiniche, M. Stougaard, 2018, Melanoma research.

E‐ to N‐cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression

S. Hamilton-Dutoit, H. Schmidt, P. Guldberg, 2013, The British journal of dermatology.

A targeted expression panel for classification, gene fusion detection and PD-L1 measurements - Can molecular profiling replace immunohistochemistry in non-small cell lung cancer?

T. Steiniche, M. Stougaard, A. T. Simonsen, 2022, Experimental and molecular pathology.

Reducing workload in malignant melanoma sentinel node examination: a national study of pathology reports from 507 melanoma patients

I. Christensen, Mathilde Skaarup Larsen, J. Lade-Keller, 2023, Journal of clinical pathology.

Examination of the Functional Relationship between PD-L1 DNA Methylation and mRNA Expression in Non-Small-Cell Lung Cancer

T. F. Daugaard, A. Nielsen, J. Lade-Keller, 2023, Cancers.

Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas.

L. Kristensen, L. Hansen, P. Guldberg, 2013, The Journal of molecular diagnostics : JMD.

Can evaluation of mismatch repair defect and TILs increase the number of triple-negative breast cancer patients eligible for immunotherapy?

T. Tramm, J. Lade-Keller, Demet Özcan, 2021, Pathology, research and practice.

Concordance in BRAF V600E status over time in malignant melanoma and corresponding metastases

K. Sloth, T. Steiniche, J. Lade-Keller, 2018, Histopathology.

A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?

L. Kristensen, L. Hansen, P. Guldberg, 2013, Journal of Clinical Pathology.

The challenges of comparing a clinically validated test to other methods.

L. Kristensen, L. Hansen, P. Guldberg, 2013, The Journal of molecular diagnostics : JMD.

Immunohistochemical double nuclear staining for cell-specific automated quantification of the proliferation index - A promising diagnostic aid for melanocytic lesions

T. Steiniche, P. S. Nielsen, J. Lade-Keller, 2024, Pathology - Research and Practice.